Clinical Trials

All Clinical Trials

Monetary Incentives to Promote Engagement with the Oklahoma Tobacco Helpline among Pregnant Women with Medicaid Protocol Number: 11111-MONETARY-INCENTIVES
Status: Open

View Details
Pre-Screening for Sensitivity to Investigational Anti-Cancer Drugs in Patients with Advanced Ovarian Cancer Protocol Number: 2X-1000
Status: Open

View Details
Phase 2, Randomized, Prospective, Open Label, Parallel-Arm, Dose Optimization Study to Investigate the Safety, Tolerability, PK/PD, and Anti-Tumor Effect of 2X- 121 in Patients with Recurrent, Advanced Ovarian Cancer Protocol Number: 2X-1002
Status: Open

View Details
A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units Manufactured by the National Cord Blood Program and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients Protocol Number: 6637-01
Status: Open

View Details
OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy Protocol Number: A012103
Status: Open

View Details
LoTam: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients with Molecular Low-risk Early-Stage Breast Cancer Protocol Number: A012301
Status: Open

View Details
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer Protocol Number: A021806
Status: Open

View Details
Randomized Phase III Trial of MFOLFIRINOX +/- NIVOLUMAB VS. FOLFOX +/- NIVOLUMAB for First - Line Treatment of Metastatic HER2-NEGATIVE Gastroesophageal Adenocarcinoma Protocol Number: A022102
Status: Open

View Details
The Janus Rectal Cancer Trial: A Randomized Phase II Trial Testing The Efficacy of Triplet Versus Doublet Chemotherapy to Achieve Clinical Complete Response in Patients With Locally Advanced Rectal Cancer Protocol Number: A022104
Status: Open

View Details
Phase II/III Second-Line NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Mutant Metastatic Pancreatic Ductal Adenocarcinoma (PLATINUM) Protocol Number: A022106
Status: Open

View Details
A Phase II Study of Dose-Dense Gemcitabine Plus Cisplatin (ddGC) in Patients With DNA Muscle-Invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious Damage Response (DDR) Gene Alterations Protocol Number: A031701
Status: Open

View Details
Phase II Study of Cabozantinib in Combination with Nivolumab and Ipilimumab in Rare Genitourinary Tumors Protocol Number: A031702
Status: Open

View Details
Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Protocol Number: A031803
Status: Open

View Details
PREcision DIagnostics in Prostate Cancer Treatment (PREDICT) Protocol Number: A032102
Status: Open

View Details
MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer Protocol Number: A032103
Status: Open

View Details